查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004243

除毛護理產品市場：依產品類型、銷售管道、性別及年齡層分類－2026-2032年全球市場預測

Hair Loss Treatment Products Market by Product Type, Distribution Channel, Gender, Age Group - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年除毛治療產品市場價值為 65.1 億美元，預計到 2026 年將成長至 69.6 億美元，複合年成長率為 7.81%，到 2032 年將達到 110.4 億美元。

主要市場統計數據
基準年 2025 65.1億美元
預計年份：2026年 69.6億美元
預測年份 2032 110.4億美元
複合年成長率 (%) 7.81%

一個綜合性的框架，涵蓋了當前的臨床、商業性和消費者趨勢，定義了除毛治療產品類型中的機會和障礙。

本執行摘要概述了當前除毛產品市場格局，重點關注正在重塑臨床和零售領域互動模式的營運、技術和消費者主導因素。該領域如今融合了醫療、美容創新和數位健康，臨床療效、監管清晰度和患者體驗共同決定了其商業性可行性。因此，相關人員必須權衡治療方法的科學複雜性與消費者對可及性、個人化和長期療效不斷​​變化的期望。

精準醫療、數位診斷以及不斷變化的患者期​​望正在重塑脫髮治療的發展重點和護理方式。

在這一領域，正在發生多項變革性變化，這些變化正在改變治療方法的研發、實施以及患者和臨床醫生對療法的認知。精準醫療方法以及對雄激素和非雄激素通路更深入的理解正在推動更具靶向性的治療方法的開發，與此同時，醫療設備技術和微創手術的進步也在拓展可行的臨床干預措施的範圍。

不斷變化的關稅體係正在推動除毛治療整個價值鏈的業務永續營運和籌資策略的重組，因此需要重新評估製造地和分銷計劃。

2025年的關稅調整帶來了一系列明確的營運和策略挑戰，這些挑戰將波及全球供應鏈、臨床採購以及製造商和服務供應商的成本結構。某些零件和成品進口關稅的提高進一步凸顯了採購柔軟性、在地化生產和供應商多元化的重要性。實際上，依賴單一國家供應商的機構正被迫重新評估供應商合約、評估近岸外包方案並重新考慮庫存策略，以維持醫療服務的連續性並保護利潤率。

詳細的細分分析顯示產品類型、通路、性別差異和年齡層如何共同決定產品採用和策略重點。

細分市場層面的趨勢揭示了各產品系列為實現廣泛應用必須應對的不同需求促進因素、臨床要求和商業性管道。在產品類型方面，注射療法（如美塑療法、富血小板血漿 (PRP) 療法和類固醇注射）強調從業人員培訓、可重複的通訊協定以及持續療效的驗證，這些都與臨床管道和醫療專業人員主導的服務密切相關。雷射治療（包括診室內雷射手術和低功率雷射設備）彌合了臨床實踐和家庭使用之間的差距，因此對臨床療效和方便用戶使用型設計提出了雙重要求。

區域監管多樣性、通路成熟度和文化偏好如何重新定義主要全球市場的進入通路和市場進入優先事項。

區域趨勢在監管方式、消費者偏好、報銷機制和基礎設施能力方面存在顯著差異，進而影響治療方法的開發和實施。在美洲，由於成熟的醫療服務網路和健全的私人保險市場，對經臨床檢驗的干涉措施和高階手術方案的需求日益成長。在該地區，治療結果​​和患者體驗數據至關重要，推動了對高品質培訓計畫和術後護理路徑的投資。

競爭格局表明，臨床可靠性、綜合服務模式和數位化病人參與是推動持續領先地位和差異化的關鍵因素。

主要企業之間的競爭格局由幾個持續存在的因素驅動：差異化的臨床證據、整合的服務交付以及日益成熟的數位化病人參與。市場領導憑藉臨床信譽和卓越服務競爭，投資於結果研究、臨床醫生培訓學院以及從術前評估到長期隨訪的品牌化患者體驗。這些投資有助於增強轉診醫生的信任，並將患者的初步興趣轉化為持續的治療依從性和重複治療。

領導者可採取切實可行的策略步驟，以協調臨床可靠性、通路準確性和營運彈性，從而獲得永續的競爭優勢。

產業領導企業應優先採取一系列切實可行的步驟，將洞察轉化為行動，從而確保永續的競爭優勢。首先，將產品開發與可驗證的臨床終點指標結合，並投資於反映真實臨床實踐的、可操作的結果研究。這種方法能夠加快臨床醫生對產品的接受度，並增強醫保報銷談判的籌碼。其次，實現採購和製造地的多元化，以降低關稅和供應鏈中斷的風險，同時探索本地組裝和夥伴關係，以保持成本競爭力並確保按時交付。

透過結合專家訪談、文件分析和檢驗的嚴格混合方法，從各種模式和市場中得出經過檢驗的見解。

本研究採用混合方法，結合質性專家訪談、文獻回顧和結構化檢驗整合，以確保獲得可靠且多方驗證的洞見。主要資訊來源包括對臨床醫生、診所營運者、供應鏈經理、監管顧問和行業策略家的訪談，以了解臨床應用、採購行為和患者偏好等方面的實際觀點。次要資訊來源包括同行評審文獻、監管指南、專利申請、臨床試驗註冊數據和企業披露信息，以檢驗研究結論並識別創新路徑。

簡明扼要地總結了實證創新、彈性運作和以病人為中心的服務體系如何決定市場領導地位和長期生存能力。

總而言之，除毛治療市場格局正因科學進步、技術創新和不斷變化的消費者期望而重塑，所有這些因素都提升了臨床證據、營運韌性和以患者為中心的服務模式的重要性。醫療服務提供者和產品開發商若能將治療效果聲明與嚴格的真實世界檢驗相結合，投資於供應鏈的柔軟性，並製定針對特定患者群體的管道策略，將更有利於獲得永續的價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：除毛治療產品市場：依產品類型分類

  • 注射療法
    • 美塑療法
    • 富血小板血漿
    • 類固醇注射
  • 雷射治療
  • 口服治療
    • 度他雄胺
    • 非那雄胺
    • 營養補充品
  • 手術治療
    • 植髮
    • 頭皮微色素沉著
    • 頭皮縮小手術
  • 局部治療
    • 複方製劑
    • 含有非那雄胺
    • 草本植物
    • 含有米諾地爾

第9章：除毛治療產品市場：依通路分類

  • 美容院
  • 診所
  • 醫院
  • 線上零售
  • 藥局

第10章 脫髮治療產品市場：性別

  • 女士
  • 男性

第11章 除毛治療產品市場：依年齡層別分類

  • 30-45歲
  • 45歲或以上
  • 30歲以下

第12章 除毛治療產品市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 除毛治療產品市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 除毛治療產品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國除毛治療產品市場

第16章 中國脫髮治療產品市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aclaris Therapeutics Inc.
  • Amway Corp.
  • Bayer Aktiengesellschaft
  • Capillus LLC
  • Church & Dwight Co. Inc.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • DS Healthcare Group Inc.
  • Eli Lilly and Company
  • Fagron NV
  • GlaxoSmithKline plc
  • Henkel AG & Co. KGaA
  • Himalaya Wellness Company
  • Hims & Hers Health Inc.
  • Johnson & Johnson Services Inc.
  • L'Oreal SA
  • Merck & Co. Inc.
  • Natura & Co Holding SA
  • Pfizer Inc.
  • Pierre Fabre Laboratories
  • Procter & Gamble Company
  • Shiseido Company Limited
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Holdings Co. Ltd.
  • Unilever PLC
Product Code: MRR-450A0628DAE4

The Hair Loss Treatment Products Market was valued at USD 6.51 billion in 2025 and is projected to grow to USD 6.96 billion in 2026, with a CAGR of 7.81%, reaching USD 11.04 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.51 billion
Estimated Year [2026] USD 6.96 billion
Forecast Year [2032] USD 11.04 billion
CAGR (%) 7.81%

A comprehensive framing of current clinical, commercial, and consumer dynamics that define opportunity and barriers across hair loss treatment product categories

This executive summary frames the contemporary landscape of hair loss treatment products by highlighting the operational, technological, and consumer-driven forces reshaping clinical practice and retail engagement. The sector now occupies an intersection of medical therapeutics, cosmetic innovation, and digital health, where clinical efficacy, regulatory clarity, and patient experience converge to determine commercial viability. As a result, stakeholders must reconcile the scientific complexity of interventions with evolving expectations around accessibility, personalization, and long-term outcomes.

Over recent cycles, investment in minimally invasive procedures, digitally enabled patient journeys, and formulation science has elevated the standard of evidence required to achieve clinical and market acceptance. Consequently, product developers and service providers must demonstrate robust safety and tolerability profiles while articulating differentiated patient benefits. In parallel, insurers, regulators, and professional associations are increasing scrutiny on clinical claims and training standards, raising the bar for market entry and scaling. Ultimately, providers who integrate rigorous clinical validation with empathetic patient engagement and scalable delivery models will shape the next phase of growth and trust within the category.

How precision therapeutics, digital diagnostics, and evolving patient expectations are reshaping development priorities and care delivery across hair loss treatments

The landscape is undergoing several transformative shifts that are altering how treatments are developed, delivered, and perceived by patients and clinicians. Precision medicine approaches and improved understanding of androgenetic and non-androgenetic pathways are driving more targeted therapeutic development, while concurrent advances in device technology and minimally invasive procedures are broadening the range of viable clinical interventions.

Concurrently, digital tools are enabling enhanced diagnostic accuracy and continuity of care, which supports remote monitoring of outcomes and adherence. This trend toward digital integration reduces friction in patient acquisition and follow-up, but it also raises expectations for interoperability, data privacy, and demonstrated clinical benefit. Alongside technological progress, shifting consumer attitudes favor holistic treatment journeys that combine clinical efficacy with aesthetic outcomes and convenience, altering demand across treatment modalities. In response, successful market participants are aligning R&D priorities with these patient-centered expectations while investing in training and infrastructure to safely scale more complex interventions.

Operational resilience and sourcing strategies compelled by evolving tariff regimes are reshaping manufacturing footprints and distribution plans across the hair loss treatment value chain

The 2025 tariff changes have introduced a distinct set of operational and strategic challenges that ripple through global supply chains, clinical procurement, and the cost structure for manufacturers and service providers. Increased import duties on select components and finished devices have amplified the importance of sourcing flexibility, localized manufacturing, and supplier diversification. In practice, organizations that relied on single-country supply sources have needed to reassess vendor contracts, evaluate nearshoring options, and consider inventory strategies to preserve continuity of care and protect margin integrity.

Beyond direct cost implications, the tariff environment has influenced route-to-market decisions, compelling some companies to favor domestic distribution partnerships or to restructure product portfolios to emphasize lower-tariff components and formulations. At the same time, the regulatory and customs complexity associated with tariff regimes has prompted service providers and clinics to reexamine procurement cycles and contract terms. Taken together, these changes have accelerated strategic moves toward resilient sourcing, localized assembly, and stronger commercial relationships in key markets as organizations seek to shield patients and providers from supply disruption and pricing volatility.

In-depth segmentation analysis showing how product types, distribution pathways, gender differentials, and age cohorts combine to determine adoption and strategic focus

Segment-level dynamics reveal differentiated demand drivers, clinical requirements, and commercial pathways that each product family must address to achieve adoption. Within product types, injection treatments such as mesotherapy, platelet-rich plasma, and steroid injections emphasize procedural training, reproducible protocols, and evidence of sustained benefit, which aligns them closely with clinical channels and practitioner-led services. Laser treatments, including in-clinic laser procedures and low-level laser devices, bridge medical settings and at-home use, creating dual imperatives for clinical efficacy and consumer-friendly design.

Oral treatments, spanning dutasteride, finasteride, and nutritional supplements, underscore the need for long-term safety data, adherence solutions, and clear risk-benefit communication, which influences regulatory positioning and prescription behavior. Surgical treatments, covering hair transplantation, scalp micropigmentation, and scalp reduction, demand high capital intensity, specialized surgical skills, and premium patient experiences, and they often transact through clinics and hospitals where procedural reputation and outcome documentation drive referrals. Topical treatments, including combination formulas, finasteride-based products, herbal-based options, and minoxidil-based therapies, compete in saturated retail and online channels and therefore require strong differentiation through formulation claims, clinical substantiation, and brand trust.

Distribution channels-spanning beauty salons, clinics, hospitals, online retail, and pharmacies-play a critical role in shaping patient access and perceived credibility. Each channel imposes distinct requirements for training, regulatory compliance, and marketing claims, influencing which products gain traction where. Gender segmentation reveals divergent treatment preferences and concern patterns between female and male patients, with adoption drivers shaped by aesthetic expectations, safety considerations, and social stigma. Age cohorts under 30, between 30 and 45, and above 45 demonstrate different openness to preventative versus restorative approaches, varying tolerance for invasive procedures, and different lifetime engagement with long-term regimens. Taken together, these segmentation layers create a matrix of opportunity where product design, communication strategy, and channel selection must be tightly aligned to the specific needs and risk tolerances of each patient group and care setting.

How regional regulatory diversity, channel maturity, and cultural preferences are redefining adoption pathways and go-to-market priorities across major global markets

Regional dynamics vary significantly in regulatory approach, consumer preferences, reimbursement practices, and infrastructure capacity, which in turn shape how treatments are developed and delivered. In the Americas, demand leans toward clinically validated interventions and premium surgical options, supported by mature provider networks and a strong private-pay market. This region places a premium on outcome data and patient experience, which drives investment in high-quality training programs and post-procedural care pathways.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and differing reimbursement landscapes create a mosaic of opportunities and barriers. Certain markets within this broad region show rapid uptake of device-based therapies and increasing acceptance of combined medical-cosmetic pathways, while others remain constrained by limited clinical capacity or divergent regulatory requirements that influence which products can scale. Trends toward harmonization of standards and regional centers of excellence are creating focal points for adoption and cross-border collaboration.

In Asia-Pacific, high population density, rising disposable income, and strong interest in minimally invasive aesthetics drive robust consumer demand for both clinic-delivered innovations and at-home devices. Rapid digital adoption and a growing number of specialized clinics accelerate patient access, but regulatory systems and quality control practices vary widely across markets. Collectively, these regional patterns underscore the need for market-specific go-to-market strategies that balance regulatory compliance, channel selection, pricing sensitivity, and culturally attuned messaging to achieve sustainable adoption across diverse geographies.

Competitive landscape trends reveal that clinical credibility, integrated service models, and digital patient engagement drive sustained leadership and differentiation

Competitive dynamics among leading firms are anchored by several persistent themes: differentiated clinical evidence, integrated service offerings, and increasingly sophisticated digital patient engagement. Market leaders are competing on a combination of clinical credibility and service excellence, investing in outcome studies, clinician training academies, and branded patient journeys that extend from pre-procedure assessment through long-term follow-up. These investments reinforce credibility with referring professionals and help convert initial interest into ongoing adherence and repeat engagement.

At the same time, strategic partnerships between device manufacturers, pharmaceutical developers, and specialty clinics are becoming more common as organizations seek to offer bundled solutions that cover diagnostic, therapeutic, and post-care needs. Firms that successfully integrate cross-functional capabilities-combining product innovation with logistics, regulatory expertise, and clinician support-tend to capture sustained preference among professional channels. Additionally, firms that harness digital platforms for remote consultation, adherence monitoring, and outcome tracking strengthen long-term patient relationships and generate real-world evidence that can further differentiate their offerings. Ultimately, market leadership favors organizations that demonstrate both clinical stewardship and operational excellence across the full treatment lifecycle.

Actionable strategic moves for leaders to align clinical credibility, channel precision, and operational resilience for sustainable competitive advantage

Industry leaders should prioritize a set of pragmatic moves to convert insight into execution and secure durable competitive advantage. First, align product development with demonstrable clinical endpoints and invest in pragmatic outcome studies that mirror real-world practice; this approach will accelerate clinician acceptance and strengthen reimbursement conversations. Second, diversify sourcing and manufacturing footprints to reduce exposure to tariff and supply-chain disruption, while considering localized assembly or partnerships to preserve cost competitiveness and delivery speed.

Third, tailor channel strategies to the nuances of each distribution pathway by matching product complexity to the channel's capability: highly procedural offerings require clinic and hospital networks, while consumer-friendly topicals and devices benefit from enhanced online retail and pharmacy presence. Fourth, develop integrated patient engagement platforms that combine pre-procedure education, adherence support, and outcome monitoring to improve retention and generate actionable real-world evidence. Fifth, pursue targeted collaborations with clinical centers and professional societies to accelerate training, validate protocols, and create referral pathways. If enacted together, these measures will strengthen market positioning, reduce operational risk, and create clearer pathways for sustainable growth across diverse patient segments and geographies.

A rigorous mixed-methods research design combining expert interviews, document synthesis, and triangulation to produce validated insights across modalities and markets

This research employed a mixed-methods approach combining qualitative expert interviews, document review, and structured evidence synthesis to ensure robust and triangulated insights. Primary inputs included interviews with clinicians, clinic operators, supply-chain managers, regulatory advisors, and industry strategists to capture on-the-ground perspectives about clinical adoption, procurement behaviors, and patient preferences. Secondary inputs consisted of peer-reviewed literature, regulatory guidelines, patent filings, clinical trial registries, and corporate disclosures to validate claims and identify innovation trajectories.

Data synthesis relied on cross-validation across sources, thematic coding of qualitative inputs, and iterative hypothesis testing to reconcile divergent viewpoints. Segment definitions were developed to reflect clinical modality, distribution pathway, demographic factors, and regional considerations, and findings were contextualized by prevailing regulatory and reimbursement environments. Limitations include variability in data availability across regions and channels and the evolving nature of clinical evidence, which requires ongoing monitoring. To mitigate these constraints, the methodology emphasized transparency around data provenance and used expert adjudication where empirical gaps existed.

Concise synthesis of how evidence-based innovation, resilient operations, and patient-centric delivery will determine market leadership and long-term viability

In summary, the hair loss treatment landscape is being redefined by a combination of scientific refinement, technological innovation, and shifting consumer expectations that collectively increase the importance of clinical evidence, operational resilience, and patient-centric delivery. Providers and product developers that align therapeutic claims with rigorous real-world validation, invest in supply-chain flexibility, and tailor channel strategies to distinct patient segments will be better positioned to capture enduring value.

The interplay of tariff-driven sourcing changes, regional regulatory differences, and rising digital engagement presents both challenges and opportunities. Those who respond with integrated solutions-linking clinical protocols, digital care pathways, and channel-appropriate commercialization-will differentiate their offerings and create defensible positions. Ultimately, a disciplined focus on measurable outcomes, scalable delivery, and empathetic patient engagement will determine which organizations lead the next phase of market evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hair Loss Treatment Products Market, by Product Type

  • 8.1. Injection Treatments
    • 8.1.1. Mesotherapy
    • 8.1.2. Platelet-Rich Plasma
    • 8.1.3. Steroid Injections
  • 8.2. Laser Treatments
  • 8.3. Oral Treatments
    • 8.3.1. Dutasteride
    • 8.3.2. Finasteride
    • 8.3.3. Nutritional Supplements
  • 8.4. Surgical Treatments
    • 8.4.1. Hair Transplantation
    • 8.4.2. Scalp Micropigmentation
    • 8.4.3. Scalp Reduction
  • 8.5. Topical Treatments
    • 8.5.1. Combination Formulas
    • 8.5.2. Finasteride-Based
    • 8.5.3. Herbal-Based
    • 8.5.4. Minoxidil-Based

9. Hair Loss Treatment Products Market, by Distribution Channel

  • 9.1. Beauty Salon
  • 9.2. Clinic
  • 9.3. Hospital
  • 9.4. Online Retail
  • 9.5. Pharmacy

10. Hair Loss Treatment Products Market, by Gender

  • 10.1. Female
  • 10.2. Male

11. Hair Loss Treatment Products Market, by Age Group

  • 11.1. 30 To 45
  • 11.2. Above 45
  • 11.3. Under 30

12. Hair Loss Treatment Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hair Loss Treatment Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hair Loss Treatment Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Hair Loss Treatment Products Market

16. China Hair Loss Treatment Products Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aclaris Therapeutics Inc.
  • 17.6. Amway Corp.
  • 17.7. Bayer Aktiengesellschaft
  • 17.8. Capillus LLC
  • 17.9. Church & Dwight Co. Inc.
  • 17.10. Cipla Ltd.
  • 17.11. Dr. Reddy's Laboratories Ltd.
  • 17.12. DS Healthcare Group Inc.
  • 17.13. Eli Lilly and Company
  • 17.14. Fagron N.V.
  • 17.15. GlaxoSmithKline plc
  • 17.16. Henkel AG & Co. KGaA
  • 17.17. Himalaya Wellness Company
  • 17.18. Hims & Hers Health Inc.
  • 17.19. Johnson & Johnson Services Inc.
  • 17.20. L'Oreal S.A.
  • 17.21. Merck & Co. Inc.
  • 17.22. Natura & Co Holding S.A.
  • 17.23. Pfizer Inc.
  • 17.24. Pierre Fabre Laboratories
  • 17.25. Procter & Gamble Company
  • 17.26. Shiseido Company Limited
  • 17.27. Sun Pharmaceutical Industries Ltd.
  • 17.28. Taisho Pharmaceutical Holdings Co. Ltd.
  • 17.29. Unilever PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MESOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MESOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MESOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PLATELET-RICH PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PLATELET-RICH PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY STEROID INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY STEROID INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY STEROID INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY LASER TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY LASER TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY LASER TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DUTASTERIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DUTASTERIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DUTASTERIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FINASTERIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FINASTERIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FINASTERIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HAIR TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HAIR TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HAIR TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SCALP MICROPIGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SCALP MICROPIGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SCALP REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SCALP REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SCALP REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COMBINATION FORMULAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COMBINATION FORMULAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COMBINATION FORMULAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FINASTERIDE-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FINASTERIDE-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FINASTERIDE-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HERBAL-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HERBAL-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HERBAL-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MINOXIDIL-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MINOXIDIL-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MINOXIDIL-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY BEAUTY SALON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY BEAUTY SALON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY BEAUTY SALON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY 30 TO 45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY 30 TO 45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY 30 TO 45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ABOVE 45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ABOVE 45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ABOVE 45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY UNDER 30, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY UNDER 30, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY UNDER 30, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 207. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 217. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY INJECTION TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY ORAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA HAIR LOSS TREATMENT PRODUCTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)